NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-357-2001-1-US-33 CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS US DIV 16/596,175 10869920 Expired PDF
NCI E-176-2015-1-US-02 COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF CERVICAL CANCER AND CERVICAL INTRAEPITHELIAL NEOPLASIA US CON 16/595,564 Pending
NIAID E-066-2020-0-EP-02 Improvement Of Trispecific Antibodies To HIV-1 By Engraftment Of The FR3 Loop Of VRC03 (FR3-03) EP ORD 19306312.0 Pending
NIAAA E-258-2012-0-US-02 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation US CON 16/594,431 11234953 Issued PDF
NICHD E-093-2017-0-US-03 ISOTROPIC GENERALIZED DIFFUSION TENSOR MRI US National Stage 16/603,205 11835611 Issued PDF
NCI E-035-2017-0-US-17 STAT3 INHIBITOR FORMULATION US National Stage 16/603,110 10913709 Issued PDF
NCATS E-130-2017-0-US-03 Target JAK2/IL11-mediated Pathway By LY2784544 To Treat Platinum Drug Resistant Ovarian Cancer US National Stage 16/500,959 Abandoned
NCI E-277-2016-0-US-03 FUNCTIONALLY-INTERDEPENDENT SHAPE SWITCHING NUCLEIC ACID NANOPARTICLES US National Stage 16/500,765 11512313 Issued PDF
NIAID E-137-2018-2-US-02 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response US National Stage 16/500,762 Pending
NCI E-067-2017-0-AU-03 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES AU National Stage 2018244371 Pending
NIAID E-083-2017-0-US-03 GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR
USE 		US National Stage 16/496,912 11235056 Issued PDF
NCI E-229-2014-0-JP-08 METHODS FOR ISOLATING T CELLS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2019-182421 Issued
NIAID E-213-2021-2-PCT-01 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems PCT PCT COMB PCT/US2019/054343 Expired
NIAID E-213-2021-2-EP-04 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems EP National Stage 19798423.0 Pending
NIAID E-213-2021-2-CA-03 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems CA National Stage 3113782 Pending
NIAID E-213-2021-2-AU-02 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems AU National Stage 2019355926 Pending
NCI E-114-2020-0-US-01 Methods and Compositions For Promoting An Immune Response and For Combination Therapy US 62/908,759 Abandoned
NCI E-067-2017-0-EP-06 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES EP National Stage 18721882.1 Issued
NCI E-067-2017-0-CH-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES CH EP 18721882.1 Issued
NCI E-067-2017-0-GB-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES GB EP 18721882.1 Issued
NCI E-067-2017-0-ES-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES ES EP 18721882.1 Issued
NCI E-067-2017-0-SE-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES SE EP 18721882.1 Issued
NCI E-067-2017-0-IT-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES IT EP 18721882.1 Issued
NCI E-067-2017-0-NL-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES NL EP 18721882.1 Issued
NCI E-067-2017-0-FR-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES FR EP 18721882.1 Issued
NCI E-067-2017-0-DE-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES DE EP 18721882.1 Issued
NCI E-116-2017-0-US-03 Human Antibodies Against CD33 US DIV 16/588,357 11464801 Issued PDF
NCI E-038-2018-0-US-04 Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy US DIV 16/588,591 11453719 Issued PDF
CC E-032-2020-0-US-01 SPECTRAL CT-BASED 511 KEV FOR POSITRON EMISSION
TOMOGRAPHY 		US ORD 16/587,789 11389127 Issued PDF
NCI E-008-2019-0-CN-08 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF CN National Stage 201980078691.8 Pending
NCI E-008-2019-0-EP-06 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF EP National Stage 19865927.8 Pending
NCI E-008-2019-0-JP-01 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF JP DIV 2023-215742 Pending
NCI E-008-2019-0-JP-04 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF JP National Stage 2021-517344 Pending
NCI E-008-2019-0-CA-07 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF CA National Stage 3114788 Pending
NCI E-008-2019-0-PCT-02 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF PCT PCT PCT/US2019/053825 Expired
NCI E-008-2019-0-AU-03 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF AU National Stage 2019347873 Pending
NCI E-067-2017-0-CN-05 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES CN National Stage 201880022673.3 Issued
NHGRI E-217-2018-0-US-01 Novel Vectors and Uses Thereof US 62/907,718 Abandoned
NCI E-067-2017-0-JP-07 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES JP National Stage 2019-553512 Issued
NEI E-251-2012-3-US-18 METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) US DIV 16/586,656 11441184 Issued PDF
NCI E-226-2014-0-US-08 ANTI-THYROGLOBULIN T CELL RECEPTORS US DIV 16/586,310 11440956 Issued PDF
NIAID E-102-2018-0-US-03 Antibody-mediated Conditioning With Immunosuppression To Enable Allogeneic Transplantation US National Stage 16/498,572 Pending
NIAID E-202-2018-0-US-02 USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION US ORD 16/584,679 11337988 Issued PDF
NHLBI E-111-2019-0-US-01 A Method To Guide Protocol Development For Magnetic Resonance Thermometry US ORD 16/583,596 11176717 Issued PDF
NHLBI E-076-2021-0-US-01 Systems And Methods For Applying Pressure To A Bodily Organ US 62/906,399 Abandoned
NCI E-215-2018-0-AU-03 2'-HALOGENATED-4'- THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF AU National Stage 2019349424 Issued
NCI E-215-2018-0-JP-07 HALOGENATED 5-AZA-T-DCYD ANALOGS AND METHODS OF USE JP National Stage 2021-516619 Issued
NIAID E-260-2014-0-US-05 RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE US DIV 16/578,748 11027007 Issued PDF
NCI E-153-2009-0-US-18 Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection US CON 16/579,583 10822588 Issued PDF
NCI E-215-2018-0-PCT-02 HALOGENATED 5-AZA-T-DCYD ANALOGS AND METHODS OF USE PCT PCT PCT/US2019/052410 Expired